SEELY LYNN sold 2.2% of their position (797.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $8.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/13/2025ACC: 0001415889-25-021694
-797.00
Net shares
Net seller
$8.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
797.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−391.00
Price / share
$10.53
Trade value
$4.12K
% of position
1.1%
8/11/2025
35.63K→35.23K
Common Stock
Direct
Shares
−406.00
Price / share
$10.34
Trade value
$4.20K
% of position
1.2%
8/12/2025
35.23K→34.83K
Total
Net shares
−797.00
Net value
-$8.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2025 | S · Sale | −391.00 | $10.53 | $4.12K | 1.1% | 35.63K | 35.23K |
| Common Stock Direct | 8/12/2025 | S · Sale | −406.00 | $10.34 | $4.20K | 1.2% | 35.23K | 34.83K |
| Total | −797.00 | -$8.31K | ||||||
Derivative Transactions0
No derivative transactions reported